PTP4A3 and cancer: Although the involvement of PTP4A3 in diseases other than cancer remains largely unexplored, it has also been identified as a potential protein biomarker and therapeutic target in Alzheimer's disease, implicated in a contributory role in the disruption of the blood–brain barrier [14].